StonvexLoading…
StonvexStonvexStonvexCore line items from SPSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $751.50M | $637.76M | $536.91M | $450.88M |
Operating Income | $118.30M | $88.88M | $77.25M | $71.18M |
Net Income | $93.34M | $77.05M | $65.82M | $55.13M |
EPS (Diluted) | $2.46 | $2.04 | $1.76 | $1.49 |
Total Assets | $1.17B | $1.03B | $823.84M | $672.91M |
Total Liabilities | $195.97M | $176.54M | $156.37M | $135.84M |
Cash & Equivalents | $151.35M | $241.02M | $219.08M | $162.89M |
Free Cash Flow OCF − CapEx | $152.27M | $137.35M | $112.54M | $80.17M |
Shares Outstanding | 37.52M | 37.66M | 36.82M | 36.16M |